Aurobindo Pharma Limited is a leading manufacturer of generic formulations and active pharmaceutical ingredients. With operations in India, the United States, Europe, and other international markets, the company offers a wide range of formulations including orals, injectables, and over-the-counter drugs. It also specializes in producing active pharmaceutical ingredients (API) for various therapeutic areas such as biosimilars, dermatology, respiratory, vaccines, peptides, oncology, hormones, and sterile products. Aurobindo Pharma is committed to providing antiretroviral drugs for individuals and children living with HIV, as well as AuroZymes, a biocatalysts product used in the pharmaceutical and chemical industries. Additionally, the company offers AuroSource, a comprehensive contract services solution that covers the entire drug lifecycle from the clinical stage to manufacturing and management in the API space, specifically for penicillins, cephalosporins, and non-beta lactams. Founded in 1986 and headquartered in Hyderabad, India, Aurobindo Pharma continues to be a trusted name in the pharmaceutical industry.
Navigation section
Aurobindo Pharma Limited
- 1,239.00 -0.50(-0.04%) 1,239.60 0.20(0.02%)
Performance
| Today's Low | Today's High | |
|---|---|---|
| 1,230.60 1,231.75 | 1,247.30 1246.75 |
| 52 Week Low | 52 Week High | |
|---|---|---|
| 958.50 (14-Feb-2024) 959.05 (14-Feb-2024) | 1,592.00 (13-Sep-2024) 1,592.55 (13-Sep-2024) |
- Open
- 1,241.10 1,246.75
- Previous Close
- 1,239.50 1,239.40
- Volume
- 6.20
- Total Traded value
- 76.79 (₹ Lakhs)
- Upper circuit
- 1,363.45 1,205.40
- Lower circuit
- 1,115.55 986.30
Market Depth
| Buy Order Quantity | Sell Order Quantity | |
|---|---|---|
| 0 | 27 |
| Bid Price | Quantity |
|---|---|
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | -- |
| Ask Price | Quantity |
|---|---|
| 1,237.10 | 27.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| 0.00 | 0.00 |
| Total: | 27 |
Fundamentals
| Market Cap: | ₹719.61 Cr |
| PE Ratio (TTM): | 34.80 |
| PB Ratio: | 3.66 |
| Industry P/E: | 19.64 |
| Debt to Equity: | - |
| ROE: | 10.53 |
| EPS (TTM): | 35.62 |
| Book Value: | 315.08 |
| Face Value: | 1.00 |
Financials
| Sep, 2023 | Jun, 2023 | Mar, 2023 | Dec, 2022 | Sep, 2022 | |
|---|---|---|---|---|---|
| Revenue | 2,668.76 Cr | 2,390.82 Cr | 3,547.44 Cr | 3,432.26 Cr | 3,025.66 Cr |
| Profit | 415.74 Cr | 335.95 Cr | 644.80 Cr | 298.82 Cr | 164.63 Cr |
| Expense | 2,226.06 Cr | 2,059.66 Cr | 3,019.58 Cr | 3,106.50 Cr | 2,857.76 Cr |
| Comprehensive income | 413.23 Cr | 337.42 Cr | 645.64 Cr | 300.50 Cr | 167.56 Cr |
| EPS | 7.10 | 5.74 | 11.00 | 5.10 | 2.81 |
| Company name | Listing date | Industry | NSE symbol BSE symbol |
|---|---|---|---|
| Aurobindo Pharma Limited | Jul, 2000 Apr, 1995 | Pharmaceuticals Pharmaceuticals | AUROPHARMA AUROPHARMA |
Shareholding pattern
Sep, 2023 Jun, 2023 Mar, 2023 Dec, 2022 Sep, 2022
Aurobindo Pharma Limited FAQ's
What is the range of today's stock performance for Aurobindo Pharma Limited?
Today's stock performance witnessed a fluctuation from a minimum of 1,230.60 on the NSE (National Stock Exchange) to a maximum of 1,247.30. Similarly, on the BSE (Bombay Stock Exchange), the stock's intraday range extended from a low of 1,231.75 to a high of 1,246.75.
What are the 52-week low and high values for Aurobindo Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 958.50 (occurred on 14-Feb-2024) and a high of 1,592.00 (achieved on 13-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 959.05 (on 14-Feb-2024), and the 52-week high is 1,592.55 (on 13-Sep-2024).
What was the opening and previous closing prices for Aurobindo Pharma Limited?
The stock's performance over the past 52 weeks reveals a low of 958.50 (occurred on 14-Feb-2024) and a high of 1,592.00 (achieved on 13-Sep-2024) on the NSE (National Stock Exchange). Similarly, on the BSE (Bombay Stock Exchange), the 52-week low is 959.05 (on 14-Feb-2024), and the 52-week high is 1,592.55 (on 13-Sep-2024).
What is the total volume and traded value for Aurobindo Pharma Limited for the day?
The total volume is 6, and the total traded value is 76.79 (₹ Lakhs).
What are the upper and lower circuit limits for Aurobindo Pharma Limited?
The upper circuit limit is 1,363.45, and the lower circuit limit is 1,115.55.
What is the market cap and PE ratio for Aurobindo Pharma Limited?
The market cap is ₹719.61 Cr, and the PE ratio (TTM) is 20.00.
What is the PB ratio, industry P/E, and debt to equity ratio for Aurobindo Pharma Limited?
The PB ratio is 3.93, industry P/E is 19.64 .
What are the financial metrics such as ROE, EPS, dividend yield, book value, and face value for Aurobindo Pharma Limited?
ROE is 10.53, EPS is 35.62, book value is 315.08
What are the revenue and profit figures for the latest quarter and previous quarters for Aurobindo Pharma Limited?
In Sep 2023, Revenue is ₹26687600000.00, and Profit is ₹4157400000.00. In Jun 2023, Revenue is ₹23908200000.00, and Profit is ₹3359500000.00.
When was Aurobindo Pharma Limited listed, and what industry does it belong to?
The company, Aurobindo Pharma Limited, was listed in Jul 2000 and belongs to the Pharmaceuticals industry. Its NSE symbol is AUROPHARMA.
What is the current shareholding pattern of the Aurobindo Pharma Limited?
As of latest available update, promoters hold 51.83%, the public holds 48.17%, and Employee Trusts holds 0.00.
The Indian Community
Public Community
Settings
Discover the vibrant tapestry of 'The Indian Community' - a melting pot of diverse cultures, traditions, and values. Explore its rich heritage, festivals, and contributions, as this online hub celebrates the essence of India's people, connecting, inspiring, and fostering unity worldwide.
- Members
- 29
- Threads
- 96
